Treatment-Resistant Epilepsy Linked to Autism
Study Shows Epilepsy in People With Autism Is Often Hard to Treat
WebMD News Archive
April 19, 2011 -- Epilepsy that is difficult to treat may be more common in those with autism than previously believed, new research suggests.
"In general, we knew prior to this study that people with autism have significantly elevated rates of epilepsy," says researcher Orrin Devinsky, MD, professor of neurology, neurosurgery, and psychiatry at the New York University School of Medicine. Devinsky is also director of the NYU Comprehensive Epilepsy Center.
In his new research, he found that epilepsy in autism is often treatment-resistant. ''Among those with autism who have epilepsy, in many cases it is difficult to control with medication,'' he says. In the small study, about 55% of those with sufficient data available had treatment-resistant epilepsy, he tells WebMD.
The research is published online in the journal Epilepsia.
It follows research published last week in the Journal of Child Neurology finding those with both autism and epilepsy have a higher death rate than those with autism alone.
Autism spectrum disorders, a group of developmental disabilities, affect about one in 110 U.S. children, according to the CDC. Epilepsy, a brain disorder involving spontaneous seizures, affects about 3 million Americans, according to the Epilepsy Foundation.
Autism Patients With Epilepsy
Devinsky evaluated the records of 127 patients with autism and at least one epileptic seizure over a 20-year period. He looked at laboratory and clinical data from the patients who had been coming to the NYU Epilepsy Center.
He defined treatment-resistant as failing two trials of tolerated drugs to treat epilepsy.
Overall, Devinsky found that 33.9% of the patients had treatment-resistant epilepsy and 27.5% were seizure-free (no seizures during a 12-month period). The other 38.6% had insufficient information or infrequent seizures and were not placed into a category.
"We only have good follow-up data on two-thirds of the 127," he says. "Of those two-thirds, more than 50% have intractable epilepsy."
Those who were treatment-resistant reported seizure onset at an earlier age than those who were seizure-free. They also had more regression in developmental tasks. And they had more delays in motor and language skills.